TOWER CELLX
LIVE

Serial Number

79307327

Owner

Tower Therapeutics Limited

Attorney

Sara M. Bauer

Filing Date

Dec 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TOWER CELLX Trademark

Serial Number: 79307327 • Registration: 7691048

TOWER CELLX is a trademark filed by Tower Therapeutics Limited on December 22, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Tower Therapeutics Limited (3 trademarks)

Fieldfisher, Riverbank House,

Entity Type: 24

Trademark Details

Filing Date

December 22, 2020

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Scientific and technological services, namely, research in the field of life sciences; scientific research and development; natural science services,namely, research in the field of life sciences; life science services, namely, life sciences research; biochemistry services,namely, biochemistry research; research and analysis in the field of biochemistry; research and analysis in the field of biotechnology; biotechnology testing; research and analysis in the field of molecular biology; genetic research; genetic testing for scientific research purposes; research and development in the field of immunology; stem cell research; medical and pharmacological research services; clinical research services; medical research services; biomedical research services; biological research and analysis; biological laboratory research and analysis services; chemical laboratory research and analysis services; medical laboratory research and analysis services; preparation of biological samples for testing and analysis; information, advisory and consultancy services relating to the aforesaid services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 29, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 29, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 21, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 26, 2024 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 23, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 23, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 23, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 23, 2023 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 24, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 6, 2023 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 20, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 31, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 31, 2022 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 13, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 19, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 19, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 19, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 17, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 19, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 29, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 29, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 23, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2021 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
May 9, 2021 NREP
APPLICATION FILING RECEIPT MAILED
Apr 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 25, 2021 REPR